Article: Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme
TLN_April2022_p342_354 (pdf)
The Lancet Neurology April2022 p342_354 (online)
from The Lancet Neurology
Article: Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme
TLN_April2022_p342_354 (pdf)
The Lancet Neurology April2022 p342_354 (online)
from The Lancet Neurology
This content isn't available right now
When this happens, it's usually because the owner only shared it with a small group of people, changed who can see it or it's been deleted.© 2026 CJD Support Group Network Australia.
The CJDSGN acknowledges the funding provided by the Department of Health
that assists towards the cost of this website.
Disclaimer Privacy Policy